Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Irinotecan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00314353
What this trial is testing

Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon

Who this might be right for
Colorectal Neoplasms
NSABP Foundation Inc 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07123441
What this trial is testing

A Study on the Efficacy and Safety of Irinotecan Liposome (II), 5-FU/LV in Combination With Bevacizumab for the Treatment of Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sanjun Cai 300
Testing effectiveness (Phase 2)Study completedNCT05630183
What this trial is testing

Botensilimab in Participants With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Agenus Inc. 81
Large-scale testing (Phase 3)Study completedNCT00045162
What this trial is testing

S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 671
Large-scale testing (Phase 3)UnknownNCT01290783
What this trial is testing

Trial of FOLF(HA)Iri Versus FOLFIRI in mCRC

Who this might be right for
Metastatic Colorectal Cancer
Alchemia Oncology 390
Early research (Phase 1)Study completedNCT00186979
What this trial is testing

Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors

Who this might be right for
Solid Tumors
St. Jude Children's Research Hospital 34
Testing effectiveness (Phase 2)Ended earlyNCT00755118
What this trial is testing

Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc

Who this might be right for
Colorectal Cancer
University Hospital of Crete 24
Early research (Phase 1)Study completedNCT01485744
What this trial is testing

LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Massachusetts General Hospital 39
Not applicableStudy completedNCT06006728
What this trial is testing

Real World Efficacy, Safety of Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in Metastatic Pancreatic Cancer After Previous Gemcitabine-based Therapy

Who this might be right for
Pancreatic Adenocarcinoma Metastatic
University Hospital, Bordeaux 58
Early research (Phase 1)Study completedNCT01930552
What this trial is testing

A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid Malignancies

Who this might be right for
Neoplasm Malignant
Sanofi 20
Testing effectiveness (Phase 2)Looking for participantsNCT06161532
What this trial is testing

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

Who this might be right for
Small Cell Carcinoma of the BladderSmall Cell Carcinoma of the Urinary TractSquamous Cell Carcinoma of the Bladder+5 more
National Cancer Institute (NCI)
Not applicableUnknownNCT02509234
What this trial is testing

Trabectedin and Irinotecan for Refractory Pediatric Sarcomas

Who this might be right for
Recurrent Childhood Soft Tissue SarcomaRecurrent Ewing SarcomaRecurrent Rhabdomyosarcoma
Technical University of Munich 30
Testing effectiveness (Phase 2)Study completedNCT02164916
What this trial is testing

S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
SWOG Cancer Research Network 106
Testing effectiveness (Phase 2)UnknownNCT02216487
What this trial is testing

Trial of FOLF(HA)Iri With Cetuximab in mCRC

Who this might be right for
Metastatic Colorectal Cancer
Western General Hospital, Australia 45
Testing effectiveness (Phase 2)Looking for participantsNCT05838521
What this trial is testing

Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical Cancer

Who this might be right for
Cervical Cancer
Yale University 20
Large-scale testing (Phase 3)UnknownNCT04912258
What this trial is testing

Preoperative Irinotecan Drug-eluting Beads for Patients With Unresectable Colorectal Liver Metastasis

Who this might be right for
Colorectal CancerLiver Metastases
Fudan University 80
Testing effectiveness (Phase 2)Study completedNCT00940316
What this trial is testing

Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Northwestern University 28
Testing effectiveness (Phase 2)Study completedNCT00003301
What this trial is testing

Irinotecan in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Early research (Phase 1)Study completedNCT00861328
What this trial is testing

Safety Study of ON 01910.Na in Combination With Irinotecan or Oxaliplatin

Who this might be right for
Advanced Solid Tumors
Traws Pharma, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT00276003
What this trial is testing

INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.

Who this might be right for
Non-Hodgkin's LymphomaCancer
University of New Mexico 22
Next Page
60